Table 2.
Issues on Retreatment after Success of Viscosupplementation | Level of Consensus | Agreement |
|
---|---|---|---|
Agree | Disagree | ||
Retreatment with VS must be considered | |||
Systematically every 6-12 months, even if patients remain asymptomatic | Strongly against | 2 | 8 |
Only if pain returns to pretreatment levels | Strong against | 2 | 8 |
Only from a certain level of pain (i.e., PASS) | Strongly in favor | 8 | 2 |
As soon as pain occurs again | Strongly in favor | 9 | 1 |
According to the patient’s wishes | Moderately in favor | 7 | 3 |
Must we retreat systematically little symptomatic patients? | |||
Yes | Weakly in favor | 6 | 4 |
Every 3 months | Strongly against | 0 | 6 |
Every 6 months | Strongly against | 1 | 5 |
Every year | Strongly against | 1 | 5 |
Yes but the time interval between 2 treatments must be adapted to the patient’s situation (i.e., age, anatomical severity, activities, etc.) | Unanimously in favor | 6 | 0 |
Which of these clinical situations may push you into retreating patients? | |||
Early stage of OA? | Strongly in favor | 9 | 1 |
Advanced stage of OA? | Strongly against | 2 | 8 |
Young age? | Strongly in favor | 9 | 1 |
Elderly | Moderately against | 3 | 7 |
Risk factors of rapid progression? | Strongly in favor | 9 | 1 |
Sports practice (leisure)? | No consensus | 5 | 5 |
Sports practice (professional)? | Strongly in favor | 9 | 1 |
Contraindication to arthroplasty? | Moderately in favor | 7 | 3 |
Severe comorbidities? | Strongly in favor | 8 | 2 |
Does the chondroprotective properties of HA influence your decision to retreat asymptomatic or little symptomatic patients with HA? | Strongly in favor | 8 | 2 |
VS = viscosupplementation; OA = osteoarthritis; PASS = Patient’s Acceptable Symptom State; HA = hyaluronic acid.